2015•Pediatric NeurologyRequires access

Use of mTOR Inhibitor Everolimus in Three Neonates for Treatment of Tumors Associated With Tuberous Sclerosis Complex

Isabelle Goyer, Nagib Dahdah, Philippe Major

Open publisher page 69 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 69 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tuberous sclerosis, Everolimus, Subependymal giant cell astrocytoma, Medicine, Subependymal zone, Sirolimus, PI3K/AKT/mTOR pathway, Discovery and development of mTOR inhibitors

Back to paper search Browse research topics Original source

Use of mTOR Inhibitor Everolimus in Three Neonates for Treatment of Tumors Associated With Tuberous Sclerosis Complex — Research Paper | ScholarLens